Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H41ClN2O9 |
| Molecular Weight | 645.14 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C(=CC=C1)[C@H]2O[C@H](CC(=O)N3CCC(CC(O)=O)CC3)C(=O)N(CC(C)(C)COC(C)=O)C4=CC=C(Cl)C=C24
InChI
InChIKey=CMLUGNQVANVZHY-POURPWNDSA-N
InChI=1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1
| Molecular Formula | C33H41ClN2O9 |
| Molecular Weight | 645.14 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. | 2011-05-10 |
|
| Squalene synthase inhibition: a novel target for the management of dyslipidemia. | 2007-01 |
|
| Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro. | 2003-07 |
|
| Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis. | 2002-09-26 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:44 GMT 2025
by
admin
on
Mon Mar 31 18:20:44 GMT 2025
|
| Record UNII |
IUH3AY74O3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
IUH3AY74O3
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
9874248
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
189060-13-7
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
SS-96
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
SUB32261
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
CHEMBL435224
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
DTXSID50432130
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
DB05317
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
C81535
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY | |||
|
100000124421
Created by
admin on Mon Mar 31 18:20:44 GMT 2025 , Edited by admin on Mon Mar 31 18:20:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE ACTIVE -> PARENT |
In RD cells inhibited cholesterol biosynthesis
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|